治疗细胞内感染的药物输送方法的荟萃分析。

Meta-Analysis of Drug Delivery Approaches for Treating Intracellular Infections.

机构信息

College of Pharmacy, Ajou University, Suwon, Gyeonggi-do, 16499, Republic of Korea.

Research Institute of Pharmaceutical Science and Technology (RIPST), Ajou University, Suwon, Gyeonggi-do, 16499, Republic of Korea.

出版信息

Pharm Res. 2022 Jun;39(6):1085-1114. doi: 10.1007/s11095-022-03188-z. Epub 2022 Feb 10.

Abstract

This meta-analysis aims to evaluate the trend, methodological quality and completeness of studies on intracellular delivery of antimicrobial agents. PubMed, Embase, and reference lists of related reviews were searched to identify original articles that evaluated carrier-mediated intracellular delivery and pharmacodynamics (PD) of antimicrobial therapeutics against intracellular pathogens in vitro and/or in vivo. A total of 99 studies were included in the analysis. The most commonly targeted intracellular pathogens were bacteria (62.6%), followed by viruses (16.2%) and parasites (15.2%). Twenty-one out of 99 (21.2%) studies performed neither microscopic imaging nor flow cytometric analysis to verify that the carrier particles are present in the infected cells. Only 31.3% of studies provided comparative inhibitory concentrations against a free drug control. Approximately 8% of studies, albeit claimed for intracellular delivery of antimicrobial therapeutics, did not provide any experimental data such as microscopic imaging, flow cytometry, and in vitro PD. Future research on intracellular delivery of antimicrobial agents needs to improve the methodological quality and completeness of supporting data in order to facilitate clinical translation of intracellular delivery platforms for antimicrobial therapeutics.

摘要

本荟萃分析旨在评估抗菌药物细胞内递药的研究趋势、方法学质量和完整性。通过检索 PubMed、Embase 和相关综述的参考文献,确定了评估载体介导的抗菌治疗剂细胞内递药和药效学(PD)的原始文章,这些研究针对体外和/或体内的细胞内病原体。共有 99 项研究纳入分析。最常见的靶向细胞内病原体是细菌(62.6%),其次是病毒(16.2%)和寄生虫(15.2%)。99 项研究中有 21 项(21.2%)既没有进行显微镜成像也没有进行流式细胞术分析来验证载体颗粒是否存在于感染细胞中。只有 31.3%的研究提供了与游离药物对照的比较抑制浓度。尽管有 8%的研究声称进行了抗菌治疗剂的细胞内递药,但没有提供任何实验数据,如显微镜成像、流式细胞术和体外 PD。未来抗菌药物细胞内递药的研究需要提高支持数据的方法学质量和完整性,以便促进细胞内递药平台在抗菌治疗中的临床转化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d104/8830998/b3eb78dc3900/11095_2022_3188_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索